Supplemental material for Impact of first-line infliximab on the pharmacokinetics of second-line vedolizumab in inflammatory bowel diseases

Liefferinckx, Claire; Verstockt, Bram; Gils, Ann; Tops, Sophie; Van Moerkercke, Wouter; Vermeire, Severine; Franchimont, Denis

doi:10.25384/SAGE.7893434.v1

Supplemental_Material.pdf (237.02 kB)

Supplemental material for Impact of first-line infliximab on the pharmacokinetics of second-line vedolizumab in inflammatory bowel diseases

journal contribution

posted on 2019-03-24, 12:00 authored by Claire Liefferinckx, Bram Verstockt, Ann Gils, Sophie Tops, Wouter Van Moerkercke, Severine Vermeire, Denis Franchimont

Supplemental Material for Impact of first-line infliximab on the pharmacokinetics of second-line vedolizumab in inflammatory bowel diseases by Claire Liefferinckx, Bram Verstockt, Ann Gils, Sophie Tops, Wouter Van Moerkercke, Severine Vermeire and Denis Franchimont in United European Gastroenterology Journal